Development and Validation of a Scoring System to Predict 2-Year Clinical Remission in Ulcerative Colitis Patients on Vedolizumab
Our study determined predictive factors and proposed a scoring system of ongoing clinical remission in UC patients on maintenance vedolizumab. In patients at high risk of relapse, combination therapy with thiopurine may be beneficial.
Authors
- Sudarshan Paramsothy (ORCID: https://orcid.org/0000-0002-9097-6028)
- Rupert W. Leong (ORCID: https://orcid.org/0000-0001-5944-3488)
- Melissa Kermeen
- Viraj C. Kariyawasam (ORCID: https://orcid.org/0000-0003-2623-1336)
- Aviv Pudipeddi (ORCID: https://orcid.org/0000-0002-3664-2246)
- Thanaboon Chaemsupaphan (ORCID: https://orcid.org/0009-0001-3408-7277)
- Huiyu Lin (ORCID: https://orcid.org/0000-0001-8779-6010)
Institutions
- The University of Sydney (AU)
- Siriraj Hospital (TH)
- Mahidol University (TH)
- Concord Repatriation General Hospital (AU)
- Blacktown & Mount Druitt Hospital (AU)
- Tan Tock Seng Hospital (SG)
- Western Sydney University (AU)
- Macquarie University (AU)
Publication Details
- Journal
- Crohn s & Colitis 360
- Published
- 2024-12-28
- DOI
- https://doi.org/10.1093/crocol/otae068
- Citations
- 1
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.55